David Andrews

Company: Imvax Inc.

Job title: Co-Founder, Chief Medical Officer

Seminars:

Goldspire™: A Unique Platform for Personalized, Whole Tumor-Derived Immunotherapy with Compelling Clinical Data in Glioblastoma 1:15 pm

Turning the complexity of the tumor against itself Personalized Immunotherapy stimulating tumor Immunogenic Cell Death Compelling Phase 1b data leading into ongoing Phase 2bRead more

day: Conference Day 2